Novavax, Inc.

NVV1.F | XETRA | 0 Sledující

€6.25

0.24%

€0.02

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 USD	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	682,162 +22.61%	556,382 -65.20%	1,598,951 +39.49%	1,146,290 -
Cost of revenue	202,739 -41.02%	343,768 -61.92%	902,639 +7,029.29%	12,661 -
Gross profit	479,423 +125.49%	212,614 -69.47%	696,312 -38.58%	1,133,629 -
Operating expense	728,354 -6.52%	779,125 -41.90%	1,341,048 -52.66%	2,832,866 -
Operating income	-248,931 +56.06%	-566,511 +12.13%	-644,736 +61.77%	-1,686,576 -
Pretax Income	-176,615 +67.48%	-543,031 +16.92%	-653,647 +61.88%	-1,714,536 -
Tax Provision	10,884 +435.89%	2,031 -52.68%	4,292 -85.31%	29,215 -
Net income	-187,499 +65.60%	-545,062 +17.16%	-657,939 +62.27%	-1,743,751 -
EPS	-1.23 +77.26%	-5.41 +35.75%	-8.42 +64.08%	-23.44 -
Diluted EPS	-1.23 +77.26%	-5.41 +35.75%	-8.42 +64.08%	-23.44 -
Average Shares	152,190 +51.03%	100,768 +28.89%	78,183 +5.08%	74,400 -
Diluted Average Shares	152,190 +51.03%	100,768 +28.89%	78,183 +5.08%	74,400 -
EBIT	-156,540 +70.39%	-528,615 +16.59%	-633,767 +62.57%	-1,693,409 -
EBITDA	-108,044 +77.83%	-487,390 +19.40%	-604,713 +64.02%	-1,680,748 -

Soubory cookie používáme ke zlepšení prohlížení na webu.